Viewing Study NCT04149067


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-22 @ 9:36 AM
Study NCT ID: NCT04149067
Status: COMPLETED
Last Update Posted: 2019-11-04
First Post: 2019-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: FIS-DAP-2016-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View